Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
08/2000
08/02/2000EP1023291A1 Dipyridoimidazolderivatives useful in treating central nervous system disorders
08/02/2000EP1023287A1 3-oxo-2(h)-1,2,4-triazine derivatives as ligands of 5ht1a receptors
08/02/2000EP1023286A1 Benzimidazole compounds, pharmaceutical compositions containing the compounds and their use
08/02/2000EP1023285A1 Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonists
08/02/2000EP1023282A1 Novel pharmaceutically active compounds, their preparation and use as ece-inhibitors
08/02/2000EP1023277A1 Novel 3,4-diarylthiazolin-2-one or -2-thione derivatives, preparation methods and uses in therapy
08/02/2000EP1023273A1 Cyclohexane derivatives difunctionalised in 1,4 as ligands of 5t h1a receptors
08/02/2000EP1023263A1 Novel vitamin d analogues
08/02/2000EP1023080A1 Ligand binding site of rage and uses thereof
08/02/2000EP1023074A1 Methods for treating psychosis associated with glucocorticoid related dysfunction
08/02/2000EP1023072A1 Analgesic compositions
08/02/2000EP1023070A1 Use of monoxidine for the treatment of depression
08/02/2000EP1023069A1 Nicotine compositions and methods of formulation thereof
08/02/2000EP1023067A2 The use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function
08/02/2000EP1023066A1 Novel pyrazole and pyrazoline substituted compounds
08/02/2000EP1023061A1 Somatostatin agonists
08/02/2000EP1023051A1 Oral morphine multiparticulate formulation
08/02/2000EP1022960A1 Composition for suppressing withdrawal symptoms and craving for alcohol in alcoholics and preventing the abuse of alcohol in healthy subjects
08/02/2000EP0885229B1 Fused pyrrolo(2,3-c)carbazole-6-ones which potentiate activity of gamma interferon
08/02/2000EP0731796B1 1,3,5-trisubstituted pyrazole compounds for treatment of inflammation
08/02/2000CN1261888A 2{4-[4-(4,5-dichloro-2-methylimidazol-1-yl) butyl]-1-piperazinyl}-5-fluoropyrimiding, preparation and therapeutic use
08/02/2000CN1261887A Azetidinyl propylpiperidine derivatives, intermediates and use as tachykinin antagonists
08/02/2000CN1261883A Novel compounds
08/02/2000CN1261882A Polymorphic form of tachykinin receptor antagonist 2-(R)-(1-(R)-(3,5-bis(trifluoromethyl) phenyl) ethoxy)-3-(S)-(4-fluoro) phenyl-4-(3-5(oxo-1H,4H-1,2,4-triazolo methylmorpholine
08/02/2000CN1261877A 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors
08/02/2000CN1261804A Pharmaceutical compositions comprising an aldose reductase inhibitor and an ACE inhibitor
08/02/2000CN1261801A Allelic polygene diagnosis of reward deficiency syndrome and treatment
08/02/2000CN1261799A Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin
08/02/2000CN1261793A Sertraline salts and substained-release dosage forms of sertraline
08/02/2000CN1261792A Gelatine encapsulated solution dosage forms of sertraline
08/02/2000CN1055089C Intermediate of protein kinase C inhibitor and its preparation
08/01/2000US6096888 Anthracyclinone derivatives and their use in amyloidosis
08/01/2000US6096885 Exhibit agonist activity for cck-a receptors thereby enabling them to modulate the hormones gastrin and cholecystokinin in mammals.
08/01/2000US6096866 Netrins
08/01/2000US6096773 Inhibitor of binding of integrin to its receptors, such as (vascular cell adhesion molecule-1) and fibronectin and useful for controlling the diseases induced by binding
08/01/2000US6096771 Isoxazole derivatives
08/01/2000US6096766 Useful in the treatment or prevention of pain, inflammation, migraine, emesis and postherpetic neuralgia
08/01/2000US6096762 Contacting nerve cells with a neurotrophic amount of difluoroamide compound with affinity for an fk-506 binding protein for stimulating neurite grwoth in nerve cells
08/01/2000US6096760 Solid α-phenyl-2-piperidine acetate free base, its preparation and use in medicine
08/01/2000US6096755 N-substituted azabicycloalkane derivatives, their preparation and use
08/01/2000US6096753 Substituted pyrimidinone and pyridone compounds and methods of use
08/01/2000US6096748 Pyrimidine compounds useful in treating cytokine mediated diseases
08/01/2000US6096743 1,2,3,4-tetrahydroquinoxalinedione derivative
08/01/2000US6096739 Treatment for CNS injuries
08/01/2000US6096737 Treatment of multiple sclerosis (MS) and other demyelinating conditions using lofepramine in combination with L-phenylalanine, tyrosine or tryptophan and possibly a vitamin B12 compound
08/01/2000US6096735 Benzoheterocyclic derivatives
08/01/2000US6096729 Use of NK-1 receptor antagonists for treating amnestic disorders
08/01/2000US6096513 Amino acid sequences; for screening agonists and antagonists; for analgesics
08/01/2000US6096317 St. John's Wort and methyl donor composition and uses thereof
08/01/2000CA2199845C Quinoxalinedione nmda receptor antagonists
08/01/2000CA2151618C Derivatives of benzoylecgonine, ecgonine and ecgonidine as medicines
08/01/2000CA2140887C New nimesulide salt cyclodextrine inclusion complexes
08/01/2000CA2066640C Heterocyclic compounds
08/01/2000CA2018308C Anticonvulsant pyrazines
08/01/2000CA2015034C Piperazine derivatives
08/01/2000CA1341064C Compounds having a cognition adjuvant action, agents containing them, and the use thereof for the treatment and prophylaxis of cognitive dysfunctions
07/2000
07/29/2000CA2260397A1 Method of converting rendered triglyceride oil from marine sources into bland, stable food oil
07/27/2000WO2000043781A2 Growth differentiation factor inhibitors and uses therefor
07/27/2000WO2000043524A1 Polypeptides derived from jnk3
07/27/2000WO2000043495A2 33 human secreted proteins
07/27/2000WO2000043419A2 Exocytosis pathway proteins and methods of use
07/27/2000WO2000043415A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
07/27/2000WO2000043414A1 Tripeptide compounds useful as selective inhibitors of aminopeptidase a and corresponding pharmaceutical compositions
07/27/2000WO2000043413A2 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by vla-4
07/27/2000WO2000043397A1 Fused heterocyclic compounds and their use in the treatment of neurodegenerative diseases
07/27/2000WO2000043394A1 Substituted nitrogen heterocyclic derivatives and pharmaceutical use thereof
07/27/2000WO2000043391A1 Substituted 1-(pieridin-4-yl)-3-(aryl) isothioureas their preparation and therapeutic application
07/27/2000WO2000043384A1 Aromatic heterocyclic compounds as antiinflammatory agents
07/27/2000WO2000043382A1 Piperidine, tetrahydropyridine and piperazine derivatives, their preparation and use
07/27/2000WO2000043378A1 New morpholinobenzamide salts
07/27/2000WO2000043373A2 Kinase inhibitors
07/27/2000WO2000043371A2 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by vla-4
07/27/2000WO2000043370A1 Telmisartan polymorphs, methods for producing same and their use in the preparation of a medicament
07/27/2000WO2000043362A1 Phenylsulphonyl derivatives as 5-ht receptor ligands
07/27/2000WO2000043058A1 Method of enhancing needleless transdermal powdered drug delivery
07/27/2000WO2000043039A1 Vaccine-mediated treatment of neurological disorders
07/27/2000WO2000043033A1 CHAPERONIN 10 AND β-INTERFERON THERAPY OF MULTIPLE SCLEROSIS
07/27/2000WO2000043023A1 Pharmaceutical composition with adhesion molecule expression regulating activity
07/27/2000WO2000043021A1 Pharmaceutical composition for the treatment of rheumatic syndromes containing sulfur, mustard seeds and a copper salt
07/27/2000WO2000043020A1 Egg anti-inflammatory composition and method of treating and preventing inflammation
07/27/2000WO2000043019A2 Egg anti-inflammatory composition and method of treating and preventing inflammation
07/27/2000WO2000043013A1 Pharmaceutical compositions for alleviating discomfort
07/27/2000WO2000043011A1 Substituted 1-(piperidin-4-yl)-3-(aryl)-isothioureas, their preparation and therapeutic use
07/27/2000WO2000043010A1 Acyl derivatives of 4-demethylpenclomedine, use thereof and preparation thereof
07/27/2000WO2000043007A1 Troglitazone-containing medicinal compositions for inhibiting apoptosis
07/27/2000WO2000043006A1 Inhibitor for nerve cell death due to glutamic acid cytotoxicity
07/27/2000WO2000043002A1 Method to aid smoking cessation
07/27/2000WO2000043001A1 Anti-inflammatory agents
07/27/2000WO2000042996A2 Use of anticonvulsant derivatives for treating cluster headaches
07/27/2000WO2000042989A2 Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules
07/27/2000WO2000042868A1 Infant formula
07/27/2000WO2000042852A1 Compounds and methods
07/27/2000WO2000028980A3 Combination of duloxetine with non-steroidal antiinflammatory drug for treating pain
07/27/2000WO2000028010A3 The genetic determination of genes and its use for the prophylaxis and therapy of diseases
07/27/2000WO2000023057A3 Atypical antiphsychotic in combination with acetylcholinesterase inhibitor for improving cognition
07/27/2000WO2000018915A3 Membrane-associated organizational proteins
07/27/2000WO2000018767A3 2-piperazino alkylamino benzoazole derivatives: dopamine receptor subtype specific ligands
07/27/2000WO2000004157A3 Cloning and characterisation of novel mammalian peptidases
07/27/2000WO1999066944A9 Methods for identifying novel multimeric agents that modulate receptors
07/27/2000WO1999060987A8 Control of pain with endogenous cannabinoids
1 ... 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 1503 1504 1505 1506 1507 1508 1509 1510 1511 1512 1513 ... 1833